Literature DB >> 18603432

New roles for pyruvate kinase M2: working out the Warburg effect.

Emily C Ferguson1, Jeffrey C Rathmell.   

Abstract

The origins and role of the Warburg effect have remained uncertain for many years. Two recent studies demonstrate that an embryonic- and cancer-cell-specific isoform of the enzyme pyruvate kinase M2 (PKM2) is regulated by binding to phospho-tyrosine motifs and promotes increased cell growth and tumor development. PKM2 enhances the use of glycolytic intermediates for macromolecular biosynthesis and tumor growth. These findings illustrate the distinct advantages of this metabolic phenotype in cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603432      PMCID: PMC2590867          DOI: 10.1016/j.tibs.2008.05.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  17 in total

1.  Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology.

Authors:  D R Plas; S Talapatra; A L Edinger; J C Rathmell; C B Thompson
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors.

Authors:  Ian F Robey; Anthony D Lien; Sarah J Welsh; Brenda K Baggett; Robert J Gillies
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 4.  Brick by brick: metabolism and tumor cell growth.

Authors:  Ralph J Deberardinis; Nabil Sayed; Dara Ditsworth; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2008-04-02       Impact factor: 5.578

5.  Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.

Authors:  Jill D Dombrauckas; Bernard D Santarsiero; Andrew D Mesecar
Journal:  Biochemistry       Date:  2005-07-12       Impact factor: 3.162

6.  Glucose transport regulation by p210 Bcr-Abl in a chronic myeloid leukaemia model.

Authors:  J Bentley; I Walker; E McIntosh; A D Whetton; P J Owen-Lynch; S A Baldwin
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

7.  Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation.

Authors:  Kay Barnes; Elizabeth McIntosh; Anthony D Whetton; George Q Daley; Johanne Bentley; Stephen A Baldwin
Journal:  Oncogene       Date:  2005-05-05       Impact factor: 9.867

8.  The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.

Authors:  K Koss; R F Harrison; J Gregory; S J Darnton; M R Anderson; J A Z Jankowski
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

Review 9.  Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.

Authors:  E Eigenbrodt; M Reinacher; U Scheefers-Borchel; H Scheefers; R Friis
Journal:  Crit Rev Oncog       Date:  1992

10.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Marian H Harris; Arvind Ramanathan; Robert E Gerszten; Ru Wei; Mark D Fleming; Stuart L Schreiber; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

View more
  32 in total

Review 1.  Human pyruvate kinase M2: a multifunctional protein.

Authors:  Vibhor Gupta; Rameshwar N K Bamezai
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

2.  Enhancing mitochondrial respiration suppresses tumor promoter TPA-induced PKM2 expression and cell transformation in skin epidermal JB6 cells.

Authors:  Jennifer A Wittwer; Delira Robbins; Fei Wang; Sarah Codarin; Xinggui Shen; Christopher G Kevil; Ting-Ting Huang; Holly Van Remmen; Arlan Richardson; Yunfeng Zhao
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-14

3.  Up-Regulation of PKM2 Relates to Retinal Ganglion Cell Apoptosis After Light-Induced Retinal Damage in Adult Rats.

Authors:  Xiaowei Yang; Hui Chen; Manhui Zhu; Rongrong Zhu; Bai Qin; Hongda Fang; Ming Dai; Aimin Sang; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2015-05-20       Impact factor: 5.046

4.  Soft Interactions with Model Crowders and Non-canonical Interactions with Cellular Proteins Stabilize RNA Folding.

Authors:  May Daher; Julia R Widom; Wendy Tay; Nils G Walter
Journal:  J Mol Biol       Date:  2017-11-08       Impact factor: 5.469

Review 5.  Dysfunction of chaperone-mediated autophagy in human diseases.

Authors:  Zhaozhong Liao; Bin Wang; Wenjing Liu; Qian Xu; Lin Hou; Jinlian Song; Qingming Guo; Ning Li
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 6.  Bioenergetic medicine.

Authors:  Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

7.  Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.

Authors:  Q Xu; L-Z Liu; Y Yin; J He; Q Li; X Qian; Y You; Z Lu; S C Peiper; Y Shu; B-H Jiang
Journal:  Oncogene       Date:  2015-02-23       Impact factor: 9.867

8.  SIRT2-Mediated Deacetylation and Tetramerization of Pyruvate Kinase Directs Glycolysis and Tumor Growth.

Authors:  Seong-Hoon Park; Ozkan Ozden; Guoxiang Liu; Ha Yong Song; Yueming Zhu; Yufan Yan; Xianghui Zou; Hong-Jun Kang; Haiyan Jiang; Daniel R Principe; Yong-Il Cha; Meejeon Roh; Athanassios Vassilopoulos; David Gius
Journal:  Cancer Res       Date:  2016-04-27       Impact factor: 12.701

9.  Systems medicine: the future of medical genomics and healthcare.

Authors:  Charles Auffray; Zhu Chen; Leroy Hood
Journal:  Genome Med       Date:  2009-01-20       Impact factor: 11.117

Review 10.  Alternative RNA splicing and cancer.

Authors:  Sali Liu; Chonghui Cheng
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-06-13       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.